A Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Qpi-1002 for the Prevention of Major Adverse Kidney Events (Make) In Subjects at High-risk for Acute Kidney Injury (Aki) Following Cardiac Surgery

Project: Research

Project Description

NMA HREC Reference Number: HREC/18/SVHM/218 (ERM Project ID 41307)
NMA SSA Reference Number: SSA/41307/MonH-2019-162249(v1)
Monash Health Ref: RES-19-0000-016X
StatusActive
Effective start/end date1/02/1931/01/24